GH Research (GHRS) Cash from Financing Activities (2021 - 2025)

GH Research (GHRS) recorded quarterly Cash from Financing Activities of -$68000.0 in Q4 2025, down 3.03% quarter-over-quarter from -$66000.0 in Q3 2025, and down 15.25% on a YoY basis from -$80240.0 in Q4 2024.

GH Research (GHRS) Cash from Financing Activities (2021 - 2025) Analysis & Trends

GH Research's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at -$68000.0 for Q4 2025.

  • In Q4 2025, Cash from Financing Activities fell 15.25% year-over-year to -$68000.0; the TTM figure through Dec 2025 stood at $139.7 million (up 46037.83% YoY), while the FY2025 annual figure was $139.7 million, up 46037.83% from the prior year.
  • Cash from Financing Activities was -$68000.0 for Q4 2025 at GH Research, down from -$66000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $286.6 million in Q4 2022 to a low of -$2.6 million in Q3 2021.
  • Historically, Cash from Financing Activities has averaged $32.7 million across 5 years, with a median of -$68000.0 in 2025.
  • Biggest YoY gain for Cash from Financing Activities was 198491.55% in 2025; the steepest drop was 841.23% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$171000.0 in 2021, then jumped by 167712.87% to $286.6 million in 2022, then tumbled by 100.02% to -$70000.0 in 2023, then climbed by 15.71% to -$59000.0 in 2024, then fell by 15.25% to -$68000.0 in 2025.
  • The last three Cash from Financing Activities figures came in at -$68000.0 (Q4 2025), -$66000.0 (Q3 2025), and -$1.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 7.00 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -600,000.00
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 53,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -538.80 Mn
9 Abivax 94.26 Bn 94.26 Bn - 85,464.43
10 GH Research 9.73 Bn 9.63 Bn - -68,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -68,000.00
Dec 31, 2025 -68,000.00
Sep 30, 2025 -66,000.00
Sep 30, 2025 -66,000.00
Jun 30, 2025 -1.07 Mn
Jun 30, 2025 -1.07 Mn
Mar 31, 2025 140.86 Mn
Mar 31, 2025 140.86 Mn
Dec 31, 2024 -59,000.00
Dec 31, 2024 -59,000.00
Sep 30, 2024 -60,000.00
Sep 30, 2024 -60,000.00
Jun 30, 2024 -114,000.00
Jun 30, 2024 -114,000.00
Mar 31, 2024 -71,000.00
Mar 31, 2024 -71,000.00
Mar 31, 2023 -70,000.00
Mar 31, 2023 -70,000.00
Dec 31, 2022 286.62 Mn
Dec 31, 2022 286.62 Mn